Search

everythinglearnresearchcommunity

for

Search:↓

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

The inhibitor affects androgen metabolism but not ovarian function.

Anastrozole and cyproterone acetate treatment can help increase adult height in boys with testotoxicosis.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

A new method was developed to make finasteride for treating hair loss.

PPX causes much less hair loss than traditional taxanes.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

New methods can detect finasteride's major urinary metabolite in urine for up to 49 hours.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The method accurately measures finasteride levels in the body.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.